Nektar Announces That FDA Grants Fast Track Designation to NKTR-181, a New …

Published June 7, 2012

Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New …

Filed under: drug treatment news 2012

SAN FRANCISCO, June 7, 2012 /PRNewswire via COMTEX/ — Nektar Therapeutics (NASDAQ:NKTR) announced today that the US Food and Drug Administration (FDA) has designated NKTR-181 as a Fast Track development program for the treatment of moderate to severe …
Read more on MarketWatch (press release)

New Drug Found Effective Against Rare Form of Basal Cell Skin Cancer

Filed under: drug treatment news 2012

ScienceDaily (June 6, 2012) — A clinical study has demonstrated that a new drug, a targeted molecular therapy called vismodegib (trade name Erivedge™), can dramatically shrink basal cell skin cancers and prevent the formation of new ones, …
Read more on Science Daily (press release)

GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia

Filed under: drug treatment news 2012

LONDON & RESEARCH TRIANGLE PARK, NC & SANTA CLARA, Calif., Jun 07, 2012 (BUSINESS WIRE) — GlaxoSmithKline plc (GSK) and XenoPort, Inc. (NASDAQ:XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved …
Read more on MarketWatch (press release)

From Twitter:

UBC drug formulation receives .1 million for clinical development as HIV treatment – HIV Haven http://t.co/u2MhhfnO – by hivhaven (HIV Haven)

From Twitter:

Did you know… Depression Treatment Can Prevent Teen Drug Abuse – About – News & Issues: PsychCentral.comDep… http://t.co/QWgYSKoI RT – by Dr_Holly (Holly Fourchalk)

From Twitter:

RT @TheStapleford: #Addiction news: Depression treatment can prevent adolescent drug abuse http://t.co/UHXQL7oP #drugs – by OWNing_JOY (Jamie Schmitt)